Treatment with transducible phosphopeptide analogues of the small heat shock-related protein, HSP20, after experimental subarachnoid hemorrhage: Prevention and reversal of delayed decreases in cerebral perfusion. Laboratory investigation

Journal of Neurosurgery

Volumn 112, Issue 3, 2010, Pages 631-639

  Furnish, Elizabeth J ^a   Brophy, Colleen M ^b   Harris, Valerie A ^c   Macomson, Samuel ^d   Winger, Julia ^c   Head, Geoffrey A ^e   Shaver, Ellen G ^c,d,f  

^a ARIZONA STATE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^f Neurological Associates of Augusta   (United States)

Author keywords

Cell permeant peptide; Cerebral perfusion; HSP20; Hypotension; Rat; Subarachnoid hemorrhage

Indexed keywords

ANTIFIBROTIC AGENT; AZX 100; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL PERFORATION; BRAIN BLOOD FLOW; BRAIN PERFUSION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; TELEMETRY;

ANIMALS; BIOMIMETICS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; HEART RATE; HEAT-SHOCK PROTEINS, SMALL; HSP20 HEAT-SHOCK PROTEINS; MALE; NEUROPROTECTIVE AGENTS; PHOSPHOPROTEINS; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 77749254748     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.7.JNS09730     Document Type: Article

References (36)

1. Amin-Hanjani S, Ogilvy CS, Barker FG II: Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54: 326-335, 2004
2. Barker FG II, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405-414, 1996
3. Beall A, Bagwell D, Woodrum D, Stoming TA, Kato K, Suzuki A, et al: The small heat shock-related protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation. J Biol Chem 274:11344-11351, 1999
4. Beall AC, Kato K, Goldenring JR, Rasmussen H, Brophy CM: Cyclic nucleotide-dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein. J Biol Chem 272:11283-11287, 1997
5. Brockway BP, Mills PA, Azar SH: A new method for continuous chronic measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin Exp Hypertens A 13:885-895, 1991
6. Brophy CM, Whitney EG, Lamb S, Beall A: Cellular mechanisms of cyclic nucleotide-induced vasorelaxation. J Vasc Surg 25:390-397, 1997
7. Dreiza CM, Brophy CM, Komalavilas P, Furnish EJ, Joshi L, Pallero MA, et al: Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics. FASEB J 19: 261-263, 2005
8. Findlay JM, Kassell NF, Weir BK, Haley EC Jr, Kongable G, Germanson T, et al: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-178, 1995
9. Flynn CR, Brophy CM, Furnish EJ, Komalavilas P, Tessier D, Thresher J, et al: Transduction of phosphorylated heat shockrelated protein 20, HSP20, prevents vasospasm of human umbilical artery smooth muscle. J Appl Physiol 98:1836-1845, 2005
10. Flynn CR, Komalavilas P, Tessier D, Thresher J, Niederkofler EE, Dreiza CM, et al: Transduction of biologically active motifs of the small heat shock-related protein HSP20 leads to relaxation of vascular smooth muscle. FASEB J 17:1358-1360, 2003
11. Gohla A, Birkenfeld J, Bokoch GM: Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics. Nat Cell Biol 7:21-29, 2005
12. Gohla A, Bokoch GM: 14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin. Curr Biol 12:1704-1710, 2002
13. Gules I, Satoh M, Clower BR, Nanda A, Zhang JH: Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol 283:H2551-H2559, 2002
14. Hansen-Schwartz J: Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology. Neurocrit Care 1:235-246, 2004
15. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH: Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 28:252-256, 2007
16. Harrod CG, Bendok BR, Batjer HH: Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 56:633-654, 2005
17. Ingall TJ, Whisnant JP, Wiebers DO, O'Fallon WM: Has there been a decline in subarachnoid hemorrhage mortality? Stroke 20:718-724, 1989
18. Institute of Laboratory Animal Research, Commisison on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996
19. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, et al: Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14:1436-1450, 2004
20. Komalavilas P, Penn RB, Flynn CR, Thresher J, Lopes LB, Furnish EJ, et al: The small heat shock-related protein, HSP20, is a cAMP-dependent protein kinase substrate that is involved in airway smooth muscle relaxation. Am J Physiol Lung Cell Mol Physiol 294:L69-L78, 2008
21. Lee KH, Lukovits T, Friedman JA: "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 4:68-76, 2006
22. Macdonald RL, Kassell N, Mayer S, Schmiedek P, Weidauer S, Pasqualin A: Randomized trial of clazosentan for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 38:462, 2007 (Abstract)
23. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebocontrolled phase 2 dose-finding trial. Stroke 39:3015-3021, 2008
24. Macomson SD, Brophy CM, Miller W, Harris VA, Shaver EG: Heat shock protein expression in cerebral vessels after subarachnoid hemorrhage. Neurosurgery 51:204-211, 2002
25. McLemore EC, Tessier DJ, Flynn CR, Furnish EJ, Komalavilas P, Thresher JS, et al: Transducible recombinant small heat shock-related protein, HSP20, inhibits vasospasm and platelet aggregation. Surgery 136:573-578, 2004
26. McLemore EC, Tessier DJ, Thresher J, Komalavilas P, Brophy CM: Role of the small heat shock proteins in regulating vascular smooth muscle tone. J Am Coll Surg 201:30-36, 2005
27. Morgan KG: Nonmuscle motility/cytoskeleton. Am J Physiol Cell Physiol 280:C1634-C1635, 2001
28. National Health and Medical Research Council: Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, ed 7. Canberra, Australia: Australian Government Publishing Service, 2004 (http://www.nhmrc.gov. au/publications/synopses/-files/ea16.pdf ) [Accessed 23 July 2009]
29. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-642, 1989
30. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572, 1999
31. Shibuya M, Asano T, Sasaki Y: Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Acta Neurochir Suppl 77:201-204, 2001
32. Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH: Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci 8:557-561, 2001
33. Tessier DJ, Komalavilas P, Liu B, Kent CK, Thresher JS, Dreiza CM, et al: Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia. J Vasc Surg 40:106-114, 2004
34. Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I: Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30:1409-1416, 1999
35. Veelken JA, Laing RJ, Jakubowski J: The Sheffield model of subarachnoid hemorrhage in rats. Stroke 26:1279-1284, 1995
36. Wadia JS, Dowdy SF: Protein transduction technology. Curr Opin Biotechnol 13:52-56, 2002